164 related articles for article (PubMed ID: 37191949)
1. Identification of nurse shark V
Buffington J; Duan Z; Kwon HJ; Hong J; Li D; Feng M; Xie H; Ho M
FASEB J; 2023 Jun; 37(6):e22973. PubMed ID: 37191949
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Ability of a Single Domain VNAR Antibody: In Vitro Neutralization of SARS-CoV-2 Variants of Concern.
Valdovino-Navarro BJ; Dueñas S; Flores-Acosta GI; Gasperin-Bulbarela J; Bernaldez-Sarabia J; Cabanillas-Bernal O; Cervantes-Luevano KE; Licea-Navarro AF
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293124
[TBL] [Abstract][Full Text] [Related]
3. Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro.
Gauhar A; Privezentzev CV; Demydchuk M; Gerlza T; Rieger J; Kungl AJ; Walsh FS; Rutkowski JL; Stocki P
FASEB J; 2021 Nov; 35(11):e21970. PubMed ID: 34637549
[TBL] [Abstract][Full Text] [Related]
4. Screening and optimization of shark nanobodies against SARS-CoV-2 spike RBD.
Liu X; Wang Y; Sun L; Xiao G; Hou N; Chen J; Wang W; Xu X; Gu Y
Antiviral Res; 2024 Jun; 226():105898. PubMed ID: 38692413
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of single domain antibodies from banded houndshark (Triakis scyllium) targeting SARS-CoV-2 spike RBD protein.
Kim WS; Chae HD; Jung I; Lee WK; Lee WJ; Lee J; Gong Y; Lee D; Kim BW; Kim JK; Hwang J; Kweon DH; Jung ST; Na JH
Fish Shellfish Immunol; 2023 Jul; 138():108807. PubMed ID: 37169112
[TBL] [Abstract][Full Text] [Related]
6. A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern.
Wu D; Cong J; Wei J; Hu J; Sun W; Ran W; Liao C; Zheng H; Ye L
Int J Nanomedicine; 2023; 18():5781-5795. PubMed ID: 37869063
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants.
Ko SH; Chen WY; Su SC; Lin HT; Ke FY; Liang KH; Hsu FF; Kumari M; Fu CY; Wu HC
J Biomed Sci; 2022 Dec; 29(1):108. PubMed ID: 36550570
[TBL] [Abstract][Full Text] [Related]
8. A Bispecific Antibody Targeting RBD and S2 Potently Neutralizes SARS-CoV-2 Omicron and Other Variants of Concern.
Yuan M; Chen X; Zhu Y; Dong X; Liu Y; Qian Z; Ye L; Liu P
J Virol; 2022 Aug; 96(16):e0077522. PubMed ID: 35916510
[TBL] [Abstract][Full Text] [Related]
9. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein.
Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H
Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430
[TBL] [Abstract][Full Text] [Related]
10. Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries.
Chen F; Liu Z; Kang W; Jiang F; Yang X; Yin F; Zhou Z; Li Z
BMC Infect Dis; 2024 Feb; 24(1):199. PubMed ID: 38350843
[TBL] [Abstract][Full Text] [Related]
11. Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.
Heo CK; Lim WH; Yang J; Son S; Kim SJ; Kim DJ; Poo H; Cho EW
Front Immunol; 2023; 14():1307693. PubMed ID: 38143750
[TBL] [Abstract][Full Text] [Related]
12. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography.
Ubah OC; Lake EW; Gunaratne GS; Gallant JP; Fernie M; Robertson AJ; Marchant JS; Bold TD; Langlois RA; Matchett WE; Thiede JM; Shi K; Yin L; Moeller NH; Banerjee S; Ferguson L; Kovaleva M; Porter AJ; Aihara H; LeBeau AM; Barelle CJ
Nat Commun; 2021 Dec; 12(1):7325. PubMed ID: 34916516
[TBL] [Abstract][Full Text] [Related]
14. A neutralizing bispecific single-chain antibody against SARS-CoV-2 Omicron variant produced based on CR3022.
Yu K; Liu B; Yu H; Sun C; Wang X; Li G; Dong M; Wang Y; Zhang J; Xu N; Liu W
Front Cell Infect Microbiol; 2023; 13():1155293. PubMed ID: 37207187
[TBL] [Abstract][Full Text] [Related]
15. ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein.
Ballmann R; Hotop SK; Bertoglio F; Steinke S; Heine PA; Chaudhry MZ; Jahn D; Pucker B; Baldanti F; Piralla A; Schubert M; Čičin-Šain L; Brönstrup M; Hust M; Dübel S
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746797
[TBL] [Abstract][Full Text] [Related]
16. Construction and next-generation sequencing analysis of a large phage-displayed V
Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
[No Abstract] [Full Text] [Related]
17. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
Li CJ; Chao TL; Chang TY; Hsiao CC; Lu DC; Chiang YW; Lai GC; Tsai YM; Fang JT; Ieong S; Wang JT; Chang SY; Chang SC
Microbiol Spectr; 2022 Apr; 10(2):e0181421. PubMed ID: 35293796
[TBL] [Abstract][Full Text] [Related]
19. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
20. Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants.
Kim JW; Cho AH; Shin HG; Jang SH; Cho SY; Lee YR; Lee S
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
